<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="89080">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01952652</url>
  </required_header>
  <id_info>
    <org_study_id>KA12/268</org_study_id>
    <nct_id>NCT01952652</nct_id>
  </id_info>
  <brief_title>Naproxen Codeine in Arthroscopic Surgery</brief_title>
  <official_title>Comparison of Post-operative Analgesic Effects of Naproxen Sodium and Naproxen Sodium-codeine Phosphate Administered Preemptively for Arthroscopic Meniscus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baskent University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baskent University</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the aim is to compare the efficacy of single dose naproxen sodium and
      combination of naproxen sodium-codeine phosphate on post-operative pain in adult patients
      undergoing arthroscopic menisectomy.Pre-emptive oral naproxen-codeine may be safely and more
      advantageous than naproxen alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients receiving preemptive oral naproxen sodium (Group N) or naproxen sodium-codeine
      phosphate (Group NC) were assigned in 2 groups.Preoperatively, drugs were given orally by a
      nurse unaware of the study to both groups within 60 minutes before surgery. Hemodynamic
      datas, possible side effects, pain and sedation levels of patients were recorded. Patient's
      pain and sedation levels were statistically assessed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain scores as measured by Visual Analogue Scale were significantly lower in Group Naproxen codeine (group NC) at all time points compared to Group Naproxen (group N) in 61 patients who underwent arthroscopic meniscus surgery.</measure>
    <time_frame>postoperative 18 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>patients will be followed postoperatively 18 hours for pain levels</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Arthroscopic Meniscus Surgery</condition>
  <arm_group>
    <arm_group_label>Group Naproxen sodium (Group N)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group N received naproxen sodium 550 mg 60 minutes before surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Naproxen sodium codeine phosphate (Group NC)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group NC received naproxen sodium 550 mg+30 mg codeine 60 minutes before surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Group N:Naproxen sodium</intervention_name>
    <description>drug will be given 60 minutes before surgery</description>
    <arm_group_label>Group Naproxen sodium (Group N)</arm_group_label>
    <other_name>Apranax fort tb, Abdi Ibrahim Ilaç,Turkiye</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Group NC :naproxen sodium codeine phosphate</intervention_name>
    <description>drug will be given 60 minutes before surgery</description>
    <arm_group_label>Group Naproxen sodium codeine phosphate (Group NC)</arm_group_label>
    <other_name>Apranax plus tb, Abdi Ibrahim Ilac, Turkey</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing arthroscopic meniscectomy were included in the study.

        Exclusion Criteria:

          -  ≤ 18 years of age

          -  hypersensitivity to non-steroidal anti-inflammatory drugs and codeine,

          -  history of peptic ulcer, gastritis, upper gastrointestinal bleeding

          -  coagulation disorder

          -  serious hepatic and renal impairment

          -  pregnancy

          -  long-term NSAID and opioid use
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anis Aribogan, Prof.,MD</last_name>
    <role>Study Director</role>
    <affiliation>Baskent University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baskent University School of Medicine Adana Teaching and Research Hospital</name>
      <address>
        <city>Adana</city>
        <zip>01250</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 26, 2013</lastchanged_date>
  <firstreceived_date>September 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baskent University</investigator_affiliation>
    <investigator_full_name>CAGLA BALI,MD</investigator_full_name>
    <investigator_title>MD,Anesthesiology and Reanimation</investigator_title>
  </responsible_party>
  <keyword>Naproxen-codeine</keyword>
  <keyword>preemptive analgesia</keyword>
  <keyword>day case surgery</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Naproxen</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
